1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chimeric Fusion Protein Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Etanercept 1.2.3 Belatacept 1.2.4 Abatacept 1.2.5 Alefacept 1.2.6 Others 1.3 Market by Application 1.3.1 Global Chimeric Fusion Protein Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Autoimmune 1.3.3 Tumor 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Chimeric Fusion Protein Market Perspective (2017-2028) 2.2 Chimeric Fusion Protein Growth Trends by Region 2.2.1 Chimeric Fusion Protein Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Chimeric Fusion Protein Historic Market Size by Region (2017-2022) 2.2.3 Chimeric Fusion Protein Forecasted Market Size by Region (2023-2028) 2.3 Chimeric Fusion Protein Market Dynamics 2.3.1 Chimeric Fusion Protein Industry Trends 2.3.2 Chimeric Fusion Protein Market Drivers 2.3.3 Chimeric Fusion Protein Market Challenges 2.3.4 Chimeric Fusion Protein Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chimeric Fusion Protein Players by Revenue 3.1.1 Global Top Chimeric Fusion Protein Players by Revenue (2017-2022) 3.1.2 Global Chimeric Fusion Protein Revenue Market Share by Players (2017-2022) 3.2 Global Chimeric Fusion Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Chimeric Fusion Protein Revenue 3.4 Global Chimeric Fusion Protein Market Concentration Ratio 3.4.1 Global Chimeric Fusion Protein Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chimeric Fusion Protein Revenue in 2021 3.5 Chimeric Fusion Protein Key Players Head office and Area Served 3.6 Key Players Chimeric Fusion Protein Product Solution and Service 3.7 Date of Enter into Chimeric Fusion Protein Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chimeric Fusion Protein Breakdown Data by Type 4.1 Global Chimeric Fusion Protein Historic Market Size by Type (2017-2022) 4.2 Global Chimeric Fusion Protein Forecasted Market Size by Type (2023-2028) 5 Chimeric Fusion Protein Breakdown Data by Application 5.1 Global Chimeric Fusion Protein Historic Market Size by Application (2017-2022) 5.2 Global Chimeric Fusion Protein Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Chimeric Fusion Protein Market Size (2017-2028) 6.2 North America Chimeric Fusion Protein Market Size by Country (2017-2022) 6.3 North America Chimeric Fusion Protein Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Chimeric Fusion Protein Market Size (2017-2028) 7.2 Europe Chimeric Fusion Protein Market Size by Country (2017-2022) 7.3 Europe Chimeric Fusion Protein Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Chimeric Fusion Protein Market Size (2017-2028) 8.2 Asia-Pacific Chimeric Fusion Protein Market Size by Country (2017-2022) 8.3 Asia-Pacific Chimeric Fusion Protein Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Chimeric Fusion Protein Market Size (2017-2028) 9.2 Latin America Chimeric Fusion Protein Market Size by Country (2017-2022) 9.3 Latin America Chimeric Fusion Protein Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chimeric Fusion Protein Market Size (2017-2028) 10.2 Middle East & Africa Chimeric Fusion Protein Market Size by Country (2017-2022) 10.3 Middle East & Africa Chimeric Fusion Protein Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Astellas Pharma 11.1.1 Astellas Pharma Company Detail 11.1.2 Astellas Pharma Business Overview 11.1.3 Astellas Pharma Chimeric Fusion Protein Introduction 11.1.4 Astellas Pharma Revenue in Chimeric Fusion Protein Business (2017-2022) 11.1.5 Astellas Pharma Recent Development 11.2 Regeneron 11.2.1 Regeneron Company Detail 11.2.2 Regeneron Business Overview 11.2.3 Regeneron Chimeric Fusion Protein Introduction 11.2.4 Regeneron Revenue in Chimeric Fusion Protein Business (2017-2022) 11.2.5 Regeneron Recent Development 11.3 Amgen 11.3.1 Amgen Company Detail 11.3.2 Amgen Business Overview 11.3.3 Amgen Chimeric Fusion Protein Introduction 11.3.4 Amgen Revenue in Chimeric Fusion Protein Business (2017-2022) 11.3.5 Amgen Recent Development 11.4 Ligand Pharmaceuticals 11.4.1 Ligand Pharmaceuticals Company Detail 11.4.2 Ligand Pharmaceuticals Business Overview 11.4.3 Ligand Pharmaceuticals Chimeric Fusion Protein Introduction 11.4.4 Ligand Pharmaceuticals Revenue in Chimeric Fusion Protein Business (2017-2022) 11.4.5 Ligand Pharmaceuticals Recent Development 11.5 Bristol-Myers Squibb 11.5.1 Bristol-Myers Squibb Company Detail 11.5.2 Bristol-Myers Squibb Business Overview 11.5.3 Bristol-Myers Squibb Chimeric Fusion Protein Introduction 11.5.4 Bristol-Myers Squibb Revenue in Chimeric Fusion Protein Business (2017-2022) 11.5.5 Bristol-Myers Squibb Recent Development 11.6 Viventia 11.6.1 Viventia Company Detail 11.6.2 Viventia Business Overview 11.6.3 Viventia Chimeric Fusion Protein Introduction 11.6.4 Viventia Revenue in Chimeric Fusion Protein Business (2017-2022) 11.6.5 Viventia Recent Development 11.7 Genzyme 11.7.1 Genzyme Company Detail 11.7.2 Genzyme Business Overview 11.7.3 Genzyme Chimeric Fusion Protein Introduction 11.7.4 Genzyme Revenue in Chimeric Fusion Protein Business (2017-2022) 11.7.5 Genzyme Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Chimeric Fusion Protein Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Etanercept Table 3. Key Players of Belatacept Table 4. Key Players of Abatacept Table 5. Key Players of Alefacept Table 6. Key Players of Others Table 7. Global Chimeric Fusion Protein Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Chimeric Fusion Protein Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Chimeric Fusion Protein Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Chimeric Fusion Protein Market Share by Region (2017-2022) Table 11. Global Chimeric Fusion Protein Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Chimeric Fusion Protein Market Share by Region (2023-2028) Table 13. Chimeric Fusion Protein Market Trends Table 14. Chimeric Fusion Protein Market Drivers Table 15. Chimeric Fusion Protein Market Challenges Table 16. Chimeric Fusion Protein Market Restraints Table 17. Global Chimeric Fusion Protein Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Chimeric Fusion Protein Market Share by Players (2017-2022) Table 19. Global Top Chimeric Fusion Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Fusion Protein as of 2021) Table 20. Ranking of Global Top Chimeric Fusion Protein Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Chimeric Fusion Protein Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Chimeric Fusion Protein Product Solution and Service Table 24. Date of Enter into Chimeric Fusion Protein Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Chimeric Fusion Protein Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Chimeric Fusion Protein Revenue Market Share by Type (2017-2022) Table 28. Global Chimeric Fusion Protein Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Chimeric Fusion Protein Revenue Market Share by Type (2023-2028) Table 30. Global Chimeric Fusion Protein Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Chimeric Fusion Protein Revenue Market Share by Application (2017-2022) Table 32. Global Chimeric Fusion Protein Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Chimeric Fusion Protein Revenue Market Share by Application (2023-2028) Table 34. North America Chimeric Fusion Protein Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Chimeric Fusion Protein Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Chimeric Fusion Protein Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Chimeric Fusion Protein Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Chimeric Fusion Protein Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Chimeric Fusion Protein Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Chimeric Fusion Protein Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Chimeric Fusion Protein Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Chimeric Fusion Protein Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Chimeric Fusion Protein Market Size by Country (2023-2028) & (US$ Million) Table 44. Astellas Pharma Company Detail Table 45. Astellas Pharma Business Overview Table 46. Astellas Pharma Chimeric Fusion Protein Product Table 47. Astellas Pharma Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 48. Astellas Pharma Recent Development Table 49. Regeneron Company Detail Table 50. Regeneron Business Overview Table 51. Regeneron Chimeric Fusion Protein Product Table 52. Regeneron Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 53. Regeneron Recent Development Table 54. Amgen Company Detail Table 55. Amgen Business Overview Table 56. Amgen Chimeric Fusion Protein Product Table 57. Amgen Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 58. Amgen Recent Development Table 59. Ligand Pharmaceuticals Company Detail Table 60. Ligand Pharmaceuticals Business Overview Table 61. Ligand Pharmaceuticals Chimeric Fusion Protein Product Table 62. Ligand Pharmaceuticals Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 63. Ligand Pharmaceuticals Recent Development Table 64. Bristol-Myers Squibb Company Detail Table 65. Bristol-Myers Squibb Business Overview Table 66. Bristol-Myers Squibb Chimeric Fusion Protein Product Table 67. Bristol-Myers Squibb Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 68. Bristol-Myers Squibb Recent Development Table 69. Viventia Company Detail Table 70. Viventia Business Overview Table 71. Viventia Chimeric Fusion Protein Product Table 72. Viventia Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 73. Viventia Recent Development Table 74. Genzyme Company Detail Table 75. Genzyme Business Overview Table 76. Genzyme Chimeric Fusion Protein Product Table 77. Genzyme Revenue in Chimeric Fusion Protein Business (2017-2022) & (US$ Million) Table 78. Genzyme Recent Development Table 79. Research Programs/Design for This Report Table 80. Key Data Information from Secondary Sources Table 81. Key Data Information from Primary Sources List of Figures Figure 1. Global Chimeric Fusion Protein Market Share by Type: 2021 VS 2028 Figure 2. Etanercept Features Figure 3. Belatacept Features Figure 4. Abatacept Features Figure 5. Alefacept Features Figure 6. Others Features Figure 7. Global Chimeric Fusion Protein Market Share by Application in 2021 & 2028 Figure 8. Autoimmune Case Studies Figure 9. Tumor Case Studies Figure 10. Others Case Studies Figure 11. Chimeric Fusion Protein Report Years Considered Figure 12. Global Chimeric Fusion Protein Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Chimeric Fusion Protein Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Chimeric Fusion Protein Market Share by Region: 2021 VS 2028 Figure 15. Global Chimeric Fusion Protein Market Share by Players in 2021 Figure 16. Global Top Chimeric Fusion Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Fusion Protein as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Chimeric Fusion Protein Revenue in 2021 Figure 18. North America Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Chimeric Fusion Protein Market Share by Country (2017-2028) Figure 20. United States Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Chimeric Fusion Protein Market Share by Country (2017-2028) Figure 24. Germany Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Chimeric Fusion Protein Market Share by Region (2017-2028) Figure 32. China Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Chimeric Fusion Protein Market Share by Country (2017-2028) Figure 40. Mexico Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Chimeric Fusion Protein Market Share by Country (2017-2028) Figure 44. Turkey Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Chimeric Fusion Protein Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Astellas Pharma Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 47. Regeneron Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 48. Amgen Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 49. Ligand Pharmaceuticals Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 51. Viventia Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 52. Genzyme Revenue Growth Rate in Chimeric Fusion Protein Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Astellas Pharma Regeneron Amgen Ligand Pharmaceuticals Bristol-Myers Squibb Viventia Genzyme